← Back to Browse
ProductDiagnostic Tests

Tumor Detection

Beijing, China

CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.

Manufactured by

Beijing, China

SynsorBio was founded in June 2020. We integrate R&D, manufacture, and sales of diagnostic reagents, NGS products and instruments. We use CRISPR as a core technology, with the combination of Microfluidics and Synthetic biology, to focus on the original R&D of emerging molecular biological techniques, together with R&D and applications of Point-of-care testing (POCT). We have obtained the authorization of CRISPR/Cas detection, which have already been industrialized into products. Moreover, we have also launched products related to NGS sample preparation, to meet the various needs of our customers. The R&D center is located in VPark in Beijing Economic and Technological Development Area, with an R&D and operation center covering an area of nearly 1,000 m 2 . At the same time, a modern integrated base including R&D, production and service has been built in Shaoxing, Zhejiang Province, with supporting production, logistics and service systems to ensure the strategic layout and business development needs. The company mainly engages in research of CRISPR-based diagnostic technology, microfluidics chip, and molecular POCT. The customers include hospitals, IVD companies, and medical laboratories, etc.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

69
Relevant manufacturers
matched to this product
99
Relevant products analyzed
for supplier coverage
13
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

12 of 99 closest product alternatives

99 products

Cancer Mutation Detection Test

GeneCker Co., Ltd. · South Korea

Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.

View Details

CRISPR Detection Test Strip

Guangzhou magigen biotechnology Co.,Ltd · China

Rapid CRISPR-based detection test strip for molecular diagnostics. Enables quick visual detection of nucleic acid targets.

View Details

Ultra-Fast detection of all Human Cancers using Non-Invasive liquid biopsy

Rapid Viral Detection Systems · United States

Point-of-care liquid biopsy platform for rapid cancer detection with 99% accuracy and high sensitivity. Delivers non-invasive screening results in minutes, enabling early diagnosis across multiple cancer types at a lower cost than conventional test kits.

View Details

Cancer Marker Detection Test

STRATEC/Diatron · Germany

In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.

View Details

Rapid Molecular Detection Technology

Origin Biotechnology Co., Ltd. · Taiwan

An advanced molecular medicine platform providing fast and precise detection of genetic markers and disease indicators. The technology addresses unmet clinical needs in genetic disease screening and diagnosis.

View Details

Pathogen Detection System

Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China

Molecular diagnostics platform for infectious disease identification and confirmation. Utilizes proprietary technology for rapid and accurate pathogen detection.

View Details

Tumor Biomarker Detection Kit

Wuhan YZY Medical Science and Technology Co.,Ltd. · China

In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.

View Details

Tumor Marker Detection Test

Hangzhou Biotest Biotech Co., Ltd · China

A diagnostic test for detecting tumor markers in patient samples. This test is used in oncology screening and monitoring.

View Details

Bladder Cancer detection.

IDL Diagnostics AB · Sweden

Point-of-care in vitro diagnostic test for rapid detection and monitoring of bladder cancer. Provides doctors' office testing capability with high sensitivity for clinical decision-making in oncological patient management.

View Details

Molecular detection

Hochuen Medical Technology Co., Ltd · China

Molecular detection devices and microfluidic systems for point-of-care and in vitro diagnostic testing. The company manufactures molecular detection components and related disposable consumables using precision molding, injection molding, laser processing, and assembly techniques. ISO 13485 certified for medical device production with capabilities spanning prototyping through large-scale manufacturing.

View Details

CTC Detection System

guangzhou biotron technolongy co.,ltd · China

A next-generation circulating tumor cell detection system based on microfluidic chips and AI interpretation that captures cancer cells from a single blood sample. It enables non-invasive tumor monitoring, assists in lung nodule diagnosis, perioperative guidance, and treatment monitoring for precision oncology.

View Details

Circulating Tumor Cell (CTC) Detection Platform

NOROVA · China

An independently developed liquid biopsy platform for detecting circulating tumor cells with high sensitivity and specificity. This non-invasive blood-based test provides comprehensive tumor-related information for malignant tumor diagnosis and treatment guidance.

View Details

87 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products